Related Experiment Videos
PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's
G Genovese1,2, L Venegoni2, D Fanoni2
1UOC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Management of chronic urticaria: Current status and future prospect.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Five-year survival impact of adjuvant anti-PD-1 therapy in a nationwide cohort of stage III melanoma.
Journal of the European Academy of Dermatology and Venereology : JEADV·2026
The mechanism of malignant progression in extramammary Paget's disease (EMPD): hallmarks of EMPD.
Medical molecular morphology·2026